top of page


Emeritus Product Visionary

Dr. Gordon Silverman, the "GO" in JOGO, is Professor Emeritus and Chair of Electrical and Computer Engineering at Manhattan College. Dr. Silverman, along with the late Joseph Brudny, M.D. ("JO" in JOGO), the former Director of the Sensory Feedback Unit at ICD Research and Rehabilitation Center in Manhattan, were the original pioneers of EMG biofeedback, creating the first ever fully-functional unit back in the 1970s.  Dr. Silverman's professional career spans more than 50 years of corporate, teaching, consulting, and research experience, during which he has developed a range of scientific instruments, particularly for use in physiological psychology research environments. He is the holder of eight patents, some of which are related to behavior modification, and is the author of more than 20 journal articles and books. Dr. Silverman has also served on the faculties of The Rockefeller University and Fairleigh Dickinson University and has research interests in telemedicine, rehabilitation medicine, artificial intelligence, and biomedical instrumentation and modeling. Dr. Silverman is the co-author of the book, "Cognitive Science: An Introduction to the Study of the Mind." 



Co-founder and President

Siva has over 23 years of clinical, safety, and postmarketing experience in the pharmaceutical industry. His previous venture, Semantelli, an AI-based drug safety detection and healthcare social media analytics platform was acquired by IQVIA, the world's leading clinical research organization with over 58,000 employees and $11 billion in revenue, where he served as a General Manager for six years.  Siva has two US patents.



Lead, Women's Health

Tiffany is an Adjunct Assistant Professor of Physical Therapy at Hunter College, New York. Tiffany received her Doctor of Physical Therapy from City University, New York, and she is pursuing her PhD in Physical Therapy at Nova Southeastern University.  



Technical Adviser

Drew has over 25 years of industry experience building mobile applications, platforms, and high-scale transactional systems.  Drew's collaboration with JOGO Health and its founder, Sanjai Murali, on product and technology topics dates back to 2011.



Head of Pelvic Floor Rehab

Uma Venkatesa is an American        Board-certified pelvic floor physiotherapist with over 30 years of experience in working closely with uro-gynecologists, obstetrician-gynecologists, and gastroenterologists in pelvic floor physiotherapy rehabilitation.

Uma worked  in Tampa, Florida  from 1992 to 2000 in several acute care and outpatient setup in several hospitals, ACLF, Women’s/ Pelvic Rehab Clinics treating  patients with  antenatal, post-natal, incontinence, aches and pain, breast cancer, stroke among female population.

Uma has presented her research at various scientific meetings.  She conducts workshops to train physiotherapists on pelvic floor dysfunctions and create awareness about pelvic floor health in educational institutions, companies, and women’s forums.

In 1991, Uma received the Best Physiotherapist Award from State and National Indian Association of Physiotherapist Conferences for her two-and-a-half-year study on interferential therapy for incontinence.



Founder and CEO

Sanjai has dedicated the last ten years of his life to working with leading clinical researchers, game designers, data scientists, and rehab professionals from various research institutes across the world to create JOGO — the first-ever digital therapeutics product that used the science of EMG biofeedback to treat neuromuscular diseases.  Sanjai has over 20 years of experience in developing and marketing technology solutions and has a US patent.



Chief Scientific Officer

Gary Krasilovsky, PT, PhD, SST was Associate Professor and Department Chair of the Hunter College DPT Program of the City University of New York from 1992 to 2018. He has been a clinician, educator, and researcher for almost forty years. Dr. Krasilovsky earned his PhD from New York University. He previously was a senior physical therapist (PT) at New York University Rusk Institute for Rehabilitation Medicine.
His positions included in-patient and out-patient PT and part time PT in the Jerry Lewis Muscular Dystrophy Clinic. Dr. Krasilovsky was an active researcher, conducting studies on EMG biofeedback for post-CVA patients (in collaboration with Dr.
Joseph Brudny) and transcutaneous nerve stimulation for chronic pain. He also received advanced training and mentoring in the electrodiagnostic department, where he performed
and trained medical residents on diagnostic EMG. Before returning to NYC and Hunter College, Dr. Krasilovsky moved to Connecticut to serve as Chief of Physical Therapy at Norwalk Hospital. In the Hunter PT Program, he taught clinical neurology, adult neurological rehabilitation, electroneuromyography, and therapeutic exercise. He has published in various peer-reviewed journals and textbooks on various areas related to physical therapy, with an emphasis on neurology-based topics.  He has been involved in multiple design versions of the EMG biofeedback system that is
today JOGO – Gx. Dr. Krasilovsky is also certified as a Schroth scoliosis therapist.

WhatsApp Image 2022-11-29 at 12.04.09 AM.jpeg


General Manager & Country Head , India

Charles Jesudasan is a pharma sales & marketing professional having 25 years of experience across multiple therapies & specialties. He started his career at Sanofi in1997 as Medical Representative, got promoted on fast track as the youngest Area Manager at the age of 25,  and the youngest Regional Manager in June 2005.


As a Regional Manager at Sanofi,  Charles grew his regional CAGR at 16% compared to the 12% national CAGR,  thanks to his consistent team building, customer engagement and  brand building discipline. 

In 2012, Charles started his career in marketing as Sr. Product Manager at Sanofi Mumbai and  soon got promoted as Marketing Manager & Marketing Head,  handling brands worth 170 crores+ across LCM & strategic projects.


In June '18, he joined Abbott India as the Business Unit head for Neurolife (475+ team size) and scripted the BU turnaround winning the Best BU award for 2019 & most profitable BU across Abbott. He moved to Abbott healthcare to turn around the CNS BU in 2020 & was again successful in driving leveraged P&L with strong double digit growth in 2021.


Charles has a B.Pharm, PGCBM -XLRI and MMM from Pondicherry University. He has contributed to the pharma industry by developing many first and second line managers in sales, marketing and  training, while maintaining high ethical standards and values.

He was awarded the Best Mentor in 2017, Brand Excellence Awards (3/6 yrs: 2012-2018), Twice nominated the OPPI awards, MD's trophy for Best RBM (2007-2009), OCS Trophy (1997-1999), Best BU in Abbott.



Vice President, Business Development

Brian comes to JOGO with 25 years of management skills gained in the life sciences sector. His experiences include the development and management of CRM tools, help desk Teams, billing applications, drug sampling tools, clinical trials applications, patient assistance programs, fleet management, marketing & sales management, medical education programs, territory development, commercial regulatory review, commercial team development & oversight, agency management, pharmaceutical business development, staff recruitment & development, P & L management and training. He served at Cegedim Dendrite, Sidmak Labs, Odyssey Pharmaceuticals, Pliva Inc., CliniSys, SpringHill Consulting, and RxCess. Brian has serviced most of the top 20 pharmaceutical companies and brings a high degree of compassion and empathy to his patient focused work. He can be reached at



Head of Clinical Research

Dr. Sunder holds an M.D. in Physical Medicine & Rehabilitation from  DR. M. G. R. Medical University, India. Dr.Sunder did his Post Graduate Diploma in Physical Medicine and Rehabilitation from Madras Medical College at the premier Government Institute of Rehabilitation Medicine, Chennai, India. He was the recipient of the Lady Tata Memorial Research Scholarship for a project on rehabilitation of upper extremity amputees and was trained in Washington, D.C. as an evaluator for an NIH-funded program on muscular dystrophy. He is an internationally-certified GCP principal investigator for clinical trials and is a regular participant in research trials.

bottom of page